Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merck & Company 126 East Lincoln Avenue Rahway NJ 07065 USA

www.merck.com P: 908-740-4000

Description:

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.

Key Statistics

Overview:

Market Capitalization, $K 307,766,912
Enterprise Value, $K 334,608,896
Shares Outstanding, K 2,532,644
Annual Sales, $ 60,115 M
Annual Net Income, $ 365,000 K
Last Quarter Sales, $ 14,631 M
Last Quarter Net Income, $ -1,226 M
EBIT, $ 2,954 M
EBITDA, $ 6,826 M
60-Month Beta 0.37
% of Insider Shareholders 0.20%
% of Institutional Shareholders 74.59%
Float, K 2,527,579
% Float 99.80%
Short Volume Ratio 0.20

Growth:

1-Year Return 16.66%
3-Year Return 56.92%
5-Year Return 46.01%
5-Year Revenue Growth 42.14%
5-Year Earnings Growth -65.21%
5-Year Dividend Growth 48.74%

Per-Share Information:

Most Recent Earnings 0.03 on 02/01/24
Latest Earnings Date 04/25/24
Earnings Per Share ttm 1.50
EPS Growth vs. Prev Qtr -98.59%
EPS Growth vs. Prev Year -98.15%
Annual Dividend Rate, $ 3.00
Annual Dividend Yield 2.47%
Most Recent Dividend 0.770 on 03/14/24
Next Ex-Dividends Date 03/14/24
Dividend Payable Date 04/05/24
Dividend Payout Ratio 195.70%
Most Recent Split 2-1 on 02/17/99

MRK Ratios

Ratio
Price/Earnings ttm 80.34
Price/Earnings forward 14.05
Price/Earnings to Growth 0.48
Return-on-Equity % 9.33%
Return-on-Assets % 3.61%
Profit Margin % 0.61%
Debt/Equity 0.89
Price/Sales 5.08
Price/Cash Flow 39.61
Price/Book 8.11
Book Value/Share 14.85
Interest Coverage -1.18

MRK Dividends

Date Value
03/14/24 $0.7700
12/14/23 $0.7700
09/14/23 $0.7300
06/14/23 $0.7300
03/14/23 $0.7300
12/14/22 $0.7300
09/14/22 $0.6900
06/14/22 $0.6900
03/14/22 $0.6900
12/14/21 $0.6900
09/14/21 $0.6500
06/14/21 $0.6500
03/12/21 $0.6500
12/14/20 $0.6500
09/14/20 $0.6100
06/12/20 $0.6100
03/13/20 $0.6100
12/13/19 $0.6100
09/13/19 $0.5500
06/14/19 $0.5500
03/14/19 $0.5500
12/14/18 $0.5500
09/14/18 $0.4800
06/14/18 $0.4800
03/14/18 $0.4800
12/14/17 $0.4800
09/14/17 $0.4700
06/13/17 $0.4700
03/13/17 $0.4700
12/13/16 $0.4700
09/13/16 $0.4600
06/13/16 $0.4600
03/11/16 $0.4600
12/11/15 $0.4600
09/11/15 $0.4500
06/11/15 $0.4500
03/12/15 $0.4500
12/11/14 $0.4500
09/11/14 $0.4400
06/12/14 $0.4400
03/13/14 $0.4400
12/12/13 $0.4400
09/12/13 $0.4300
06/13/13 $0.4300
03/13/13 $0.4300
12/13/12 $0.4300
09/13/12 $0.4200
06/13/12 $0.4200
03/13/12 $0.4200
12/13/11 $0.4200
09/13/11 $0.3800
06/13/11 $0.3800
03/11/11 $0.3800
12/13/10 $0.3800
09/13/10 $0.3800
06/11/10 $0.3800
03/11/10 $0.3800
12/11/09 $0.3800
09/02/09 $0.3800
06/04/09 $0.3800
03/04/09 $0.3800
12/03/08 $0.3800
09/03/08 $0.3800
06/04/08 $0.3800
03/05/08 $0.3800
12/05/07 $0.3800
09/05/07 $0.3800
06/06/07 $0.3800
03/07/07 $0.3800
12/06/06 $0.3800
08/30/06 $0.3800
05/31/06 $0.3800
03/08/06 $0.3800
11/30/05 $0.3800
08/31/05 $0.3800
06/01/05 $0.3800
03/02/05 $0.3800
12/01/04 $0.3800
09/01/04 $0.3800
06/02/04 $0.3700
03/03/04 $0.3700
12/03/03 $0.3700
09/03/03 $0.3700
08/20/03 $2.8760
06/04/03 $0.3600
03/05/03 $0.3600
12/04/02 $0.3600
09/04/02 $0.3600
06/05/02 $0.3500
03/06/02 $0.3500
12/05/01 $0.3500
08/30/01 $0.3500
05/31/01 $0.3400
03/07/01 $0.3400
12/06/00 $0.3400
08/30/00 $0.3400
05/31/00 $0.2900
03/01/00 $0.2900
12/01/99 $0.2900
09/01/99 $0.2900
06/02/99 $0.2700
03/03/99 $0.2700
12/02/98 $0.2700
09/02/98 $0.2700
06/03/98 $0.2250
03/04/98 $0.2250
12/03/97 $0.2250
09/03/97 $0.2250
06/05/97 $0.2100
03/05/97 $0.2100
12/05/96 $0.2000
09/04/96 $0.2000
06/06/96 $0.1700
03/06/96 $0.1700
12/06/95 $0.1700
09/05/95 $0.1700
06/02/95 $0.1500
03/03/95 $0.1500
12/02/94 $0.1500
09/02/94 $0.1500
06/02/94 $0.1400
03/02/94 $0.1400
12/02/93 $0.1400
09/02/93 $0.1400
06/02/93 $0.1250
03/02/93 $0.1250
12/02/92 $0.1250
08/31/92 $0.1250
06/02/92 $0.1150
03/02/92 $0.1150
12/02/91 $0.1050
08/30/91 $0.1050
06/03/91 $0.0933
03/04/91 $0.0933
12/03/90 $0.0933
08/28/90 $0.0933
05/29/90 $0.0750
03/05/90 $0.0750
12/04/89 $0.0750
08/29/89 $0.0750
05/30/89 $0.0683
03/02/89 $0.0683
11/29/88 $0.0617
08/29/88 $0.0492
06/03/88 $0.0533
02/29/88 $0.0533
12/01/87 $0.0444
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar